Sidhaant Life Sciences Private Limited

Sidhaant Life Sciences Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U51397DL2004PTC129632 Incorporated 01 October 2004 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME
Revenue · FY 2025
₹146.4 Cr
▲ 71% YoY
Net profit · FY 2025
₹5.36 Cr
Net margin 3.7%
EBITDA · FY 2025
₹10.77 Cr
EBITDA margin 7.4%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹76.5 Lakh
Issued & subscribed
Open charges
₹24.64 Cr
Satisfied ₹11 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
16
Provident fund records

About Sidhaant Life Sciences Private Limited

Data last updated:

Sidhaant Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 October 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2004PTC129632. Its GSTIN is 07AAICS4211N1Z6 (Delhi). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹76.5 Lakh. It is led by directors including Sudarshan Sabharwal and Jetender Sabharwal.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 808 8th Floor Vishal Towerdistrict Centre Janakpuri, New Delhi, Delhi, India – 110058.

As per the financials filed for FY 2025, the company reported a revenue of ₹146.4 Cr, a growth of 71% compared to the previous year. For the same year it recorded a net profit of ₹5.36 Cr (net margin 3.7%) and EBITDA of ₹10.77 Cr (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 7% over five years.

The company has about 16 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Sidhaant Life Sciences. As per MCA filings, the company has open charges of ₹24.64 Cr and satisfied charges of ₹11 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it. The company has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹65.9 Lakh; the latest was in December 2023. Its 7 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 4 smaller; the largest is Amvigor Organics Private Limited with revenue of ₹151.34 Cr.

Sidhaant Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-DL-11-0018066). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website smplgroup.org.

Company details

CIN U51397DL2004PTC129632
Registration Number 129632
Incorporation Date 01 October 2004
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-DL-11-0018066

Recognitions & Rankings of Sidhaant Life Sciences

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-DL-11-0018066

Contact details

Sidhaant Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its website is smplgroup.org. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    808 8th Floor Vishal Towerdistrict Centre Janakpuri, New Delhi, Delhi, India – 110058
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Sidhaant Life Sciences Private Limited, buy the company report.

Comprehensive company report
Sidhaant Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Sidhaant Life Sciences operates one associated brand: Sidhaant Life Sciences. Each brand links to its own profile.

BrandDescriptionWebsite
Provider of pharmaceutical products with a focus on export marketsidhaantlifesciences.com

Business activity

The main business activity of Sidhaant Life Sciences is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Sidhaant Life Sciences Private Limited, buy the company report.

Financials of Sidhaant Life Sciences Private Limited

FY 2024 filings available

Sidhaant Life Sciences Private Limited reported revenue of ₹146.4 Cr (up 71% YoY) for FY 2025.

Revenue · FY 2025
₹146.4 Cr ▲ 71%
Net profit · FY 2025
₹5.36 Cr margin 3.7%
EBITDA · FY 2025
₹10.77 Cr margin 7.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 71%
3 years · compounded
▲ 5%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 24%
3 years · compounded
▼ 21%
5 years · compounded
▼ 7%

Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 71% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.77 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.36 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.4%
Net Profit Margin3.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sidhaant Life Sciences Private Limited, buy the company report.

Board of directors of Sidhaant Life Sciences Private Limited

Sidhaant Life Sciences has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sudarshan SabharwalDirector01 Oct 200422 Years 1 MonthsCurrent
Jetender SabharwalDirector01 Oct 200422 Years 1 MonthsCurrent
Anu NayyarDirector31 Mar 20179 Years 7 MonthsCurrent
Sidhaant SabharwalAdditional Director31 May 20188 Years 5 MonthsCurrent
Sulabh NayyarDirector15 Jun 200917 Years 5 MonthsCurrent

Peer comparison

Sidhaant Life Sciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Amvigor Organics Private Limited₹151.34 Cr (FY 2025)46.0%Mumbai, Maharashtra, India
Kapbro Pharma Private Limited₹149.03 Cr (FY 2024)32.0%New Delhi, Delhi, India
Caritas Healthcare Private Limited₹146.85 Cr (FY 2025)39.0%Ahmedabad, Gujarat, India
Sidhaant Life Sciences Private Limitedthis company₹146.4 Cr (FY 2025)₹5.36 Cr3.7%71.0%16New Delhi, Delhi, India
N.R. Pharmaceuticals Private Limited₹144.8 Cr (FY 2024)13.0%Kolkata, West Bengal, India
Sinkhai Healthcare Limited₹144.67 Cr (FY 2025)18.0%Mumbai, Maharashtra, India
Doshi Medicare Private Limited₹143.56 Cr (FY 2024)6.0%Mumbai, Maharashtra, India
Milton Medicare Private Limited₹143.31 Cr (FY 2025)11.0%Mumbai, Maharashtra, India

To see the full peer comparison of Sidhaant Life Sciences Private Limited, buy the company report.

Auditor

Sidhaant Life Sciences Private Limited is audited by J.S. SACHDEVA & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
J.S. SACHDEVA & CO.FY 2023017415N

Shareholding

The shareholding of Sidhaant Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sidhaant Life Sciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹24.64 Cr
Satisfied charges
₹11 Cr
Breakdown by lending institutions
Others₹21.00 Cr
Hdfc Bank Limited₹2.74 Cr
Axis Bank Limited₹0.90 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
22 Sep 2025101177941Others₹60 LakhOpen
28 Sep 2024101014422Hdfc Bank Limited₹1.24 CrOpen
25 May 2022100597011Hdfc Bank Limited₹1.5 CrOpen
02 Dec 2021100531363Axis Bank Limited₹89.8 LakhOpen
19 Mar 2021100435021Others₹2.4 CrOpen

To see the full charge records of Sidhaant Life Sciences Private Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Sidhaant Life Sciences Private Limited has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹65.9 Lakh; the latest was in December 2023.

Total deals
7
Funding rounds
4
Secondary share transfers
3
Disclosed funding
₹65.9 Lakh

Deals on record (5 of 7)

WhenDealAmountParties
Dec 2023Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Mar 2019Secondary share transferUndisclosedBuyer: an individual
Seller: 4 individuals
Mar 2017Funding round₹26.5 LakhInvestors: 4 individuals
Mar 2015Funding round₹30 LakhInvestors: 4 individuals
Mar 2015Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals

To see the full deal history of Sidhaant Life Sciences Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Sidhaant Life Sciences Private Limited was last rated by Crisil on 20 Aug 2020.

Rating agencyRated onRating
Crisil20 Aug 2020

To see the full credit ratings and regulatory alerts of Sidhaant Life Sciences Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sidhaant Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Sidhaant Life Sciences Private Limited has a workforce of 16 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
16
Active EPFO establishments
1
Employee growth
6.7%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2716
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18

To see the full employee and EPFO history of Sidhaant Life Sciences Private Limited, buy the company report.

GST

Sidhaant Life Sciences has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07AAICS4211N1Z6DelhiActive01 Jul 2017
06AAICS4211N1Z8HaryanaActive02 Jan 2020

To see the full GST registrations and return filing status of Sidhaant Life Sciences Private Limited, buy the company report.

Recent activity

Sidhaant Life Sciences Private Limited has 8 board changes on record since 2004: 5 appointments and 3 cessations. The latest: Sidhaant Sabharwal was appointed as Additional Director on 31 May 2018.

Charges
A charge with Others amounted to Rs. 0.60 Cr with Charge ID 101177941 was registered on 22 Sep 2025.
AGM
Sidhaant Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.24 Cr with Charge ID 101014422 was registered on 28 Sep 2024.
Filing
Sidhaant Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Others of Rs. 18.00 Cr registered on 14 Dec 2018 with Charge ID 100224924 was modified on 23 Nov 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.50 Cr with Charge ID 100597011 was registered on 25 May 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.90 Cr with Charge ID 100531363 was registered on 02 Dec 2021.
Charges
A charge with Others amounted to Rs. 2.40 Cr with Charge ID 100435021 was registered on 19 Mar 2021.
Charges
A charge registered on 03 Aug 2007 via Charge ID 10064946 with Others was fully satisfied on 29 Feb 2020.
Charges
A charge with Others amounted to Rs. 18.00 Cr with Charge ID 100224924 was registered on 14 Dec 2018.
Appointed
Sidhaant Sabharwal was appointed as Additional Director.
Charges
A charge with Others of Rs. 11.00 Cr registered on 03 Aug 2007 with Charge ID 10064946 was modified on 07 May 2018.

9 earlier events are in the company report.

Frequently asked questions

Sidhaant Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 October 2004 (22+ years old) and is registered under CIN U51397DL2004PTC129632.

Sidhaant Life Sciences has 5 current directors:

The latest financial statements of Sidhaant Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Sidhaant Life Sciences is 07AAICS4211N1Z6, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAICS4211N1Z8 (Haryana).

The CIN (Corporate Identification Number) of Sidhaant Life Sciences is U51397DL2004PTC129632. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sidhaant Life Sciences has 5 court cases on record: 1 filed by the company and 4 filed against it. Most are in the district courts.

Sidhaant Life Sciences was incorporated on 01 October 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.

Sidhaant Life Sciences has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹65.9 Lakh; the latest was in December 2023.

The peers of Sidhaant Life Sciences by revenue are Amvigor Organics Private Limited, Kapbro Pharma Private Limited, Caritas Healthcare Private Limited, N.R. Pharmaceuticals Private Limited, Sinkhai Healthcare Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Sidhaant Sabharwal was appointed as Additional Director on 31 May 2018. Anu Nayyar ceased to be Additional Director on 30 Sep 2017. Tanya Sethi ceased to be Additional Director on 30 Sep 2017. Sidhaant Life Sciences has 8 board changes on record in total.

Yes, Sidhaant Life Sciences is registered as an MSME under Udyam registration (number: UDYAM-DL-11-0018066).